Leading the way in Infection Prevention and Wound Care Solutions
Bravida is redefining what’s possible in wound care and infection prevention, with a portfolio of transformative products and technologies that are clinically proven to deliver uncompromising freedom and protection.
Our Brands
Men’s Liberty
A discreet external male urinary collection device designed to manage urinary incontinence effectively in combination with world class securement solutions
Silverlon
Wound dressings that have a silver plated technology delivering antimicrobial benefits in the dressing without staining the skin and without increasing bioburden
Anasept
An antimicrobial cleanser, gel and irrigation solution that breaks down and removes micro-organisms in the wound bed without damaging healthy cells and tissue
Silversept
Silversept functions as a long-lasting, antimicrobial barrier by inhibiting the growth of bacteria including the antibiotic resistant strains: MRSA & VRE, as well as, clinically important fungi such as: Candida albicans and Aspergillus niger.
Bravida’s Innovative Solutions Impact Clinical Outcomes:
Wound Care
Chronic wounds impact the quality of life of many people across the globe. For example, in the United States, it affects nearly 2.5% (more than 8 million people).
Urology
In the United States, up to 80% of complicated urinary tract infections are attributable to indwelling urinary catheters. (36)
Vascular Access
CLABSIs are associated with a high-cost burden, accounting for approximately $46,000 per case. (34)
Surgical Site
Infections
Surgical site infections are the most frequent type of healthcare-associated infections, accounting for 14% − 25% of the total hospital-acquired infections. (32)
Burn
Methicillin-resistant S. aureus now is one of the leading organisms causing invasive infection in burns across the world, with burn units reporting rates of infection greater than 50%. (38)
Mechanical Circulatory Support
The overall mortality for driveline infection was 11.5%. (33)
Hospital-acquired infections during ECMO is 10–12% and their occurrence is likely to be more frequent compared with other critically ill patients. (40)
Some of Our Products
.jpeg)
Discover the benefits that Bravida Medical products can offer your patients.
